medical science

SINGAPORE (June 6): Acromec has entered into a letter of intent (LOI) to collaborate on owning and operating a private fertility centre backed by a “leading US fertility centre” as a strategic investor and advisor.  

SINGAPORE (April 5): CIMB Research is maintaining its “add” recommendation on Tianjin Zhongxin Pharmaceutical Group with an unchanged target price of US$1.30 ($1.82) as it continues to like the S-share as a “cheap proxy for China’s growing pharmac

SINGAPORE (March 22): Catalist-listed QT Vascular says a New York-based private alternative investment group, GEM Global Yield Fund, has agreed to provide it with up to $10 million in capital commitment over the next 30 months.